News
06-17-2010, 02:21 AM
OncoMed Pharmaceuticals, Inc. and Bayer Schering Pharma AG, Germany, today announced a global strategic alliance to discover, develop and commercialize novel anti-cancer stem cell therapeutics targeting the Wnt signaling pathway. Cancer stem cells are a subset of tumor cells believed to play a significant role in the establishment, metastasis and recurrence of cancer.
More... (http://www.news-medical.net/news/20100617/OncoMed-Bayer-Schering-Pharma-to-develop-and-commercialize-novel-anti-cancer-stem-cell-therapeutics.aspx)
More... (http://www.news-medical.net/news/20100617/OncoMed-Bayer-Schering-Pharma-to-develop-and-commercialize-novel-anti-cancer-stem-cell-therapeutics.aspx)